EDITORS GUNDA GEORG
SHAOMENG WANG
University of Minnesota 612-624-6184
[email protected] University of Michigan 734-615-2399
[email protected] ASSOCIATE EDITORS Jürgen Bajorath University of Bonn
[email protected] Stuart Conway University of Oxford
[email protected] Ke Ding Jinyan University
[email protected] Brian S. J. Blagg University of Notre Dame
[email protected] Mark Cushman Purdue University
[email protected] Carrie Haskell-Luevano University of Minnesota
[email protected] Maria Laura Bolognesi University of Bologna
[email protected] William Denny University of Auckland
[email protected] Ulrike Holzgrabe University of Würzburg
[email protected] Hualiang Jiang Shanghai Institute of Materia Medica
[email protected] Nouri Neamati University of Michigan
[email protected] DRUG ANNOTATIONS EDITORS
PERSPECTIVE EDITOR
EDITOR EMERITUS
Carlos Garcia-Echeverria Sanofi 612-624-6184
[email protected] Nicholas Meanwell Bristol-Myers Squibb 609-252-6195
[email protected] Philip S. Portoghese University of Minnesota
Jeff Zablocki Gilead Sciences Inc. 612-624-6184
[email protected] MANAGING EDITOR Lorraine Clark
[email protected] EDITORIAL ADVISORY BOARD Courtney C. Aldrich University of Minnesota, USA Jane Aldrich University of Florida, USA Karl-Heinz Altmann ETH Zurich, Switzerland Jonathan Baell Monash University, Australia Julian Blagg Institute of Cancer Research, UK Joanne Bronson Bristol-Myers Squibb, USA Giuseppe Campiani University of Siena, Italy Carsten Carlberg University of Eastern Finland, Finland Ji-Wang Chern National Taiwan University, Taiwan Kelly Chibale University of Cape Town, South Africa Miles Congreve Heptares Therapeutics, UK Wibke Diederich University of Marburg, Germany Stevan Djuric AbbVie, USA Jason E. Gestwicki University of California, San Francisco, USA Michael K. Gilson University of California, San Diego, USA R. Kiplin Guy University of Kentucky, USA Rolf W. Hartmann Saarland University, Germany Ajay Jain University of California, San Francisco, USA Lak Shin Jeong Seoul National University, Republic of Korea Lucienne Juillerat-Jeanneret CHUV-University of Lausanne, Switzerland
Alan P. Kozikowski StarWise Therapeutics LLC, USA Luhua Lai Peking University, China Stefan A. Laufer University of Tübingen, Germany Jeewoo Lee Seoul National University, Republic of Korea Jing-Ping Liou Taipei Medical University, Taiwan Hong Liu Shanghai Institute of Materia Medica, China Hans Matter Sanofi-Aventis Pharma Deutschland GmbH, Germany Christopher R. McCurdy University of Florida, USA Vincent Mikol Sanofi-Aventis, France Carlos Alberto Montanari University of Sao Paulo, Brazil Susan L. Mooberry University of Texas Health Science Center, USA Ettore Novellino University of Naples, Italy Dafydd R. Owen Pfizer, Inc., USA Sally-Ann Poulsen Griffith University, Australia Juan Bautista Rodriguez University of Buenos Aires, Argentina Raffaella Rossin Tagworks Pharmaceuticals, Netherlands Joachim Rudolph Genentech, USA Chunquan Sheng Second Military Medical University, China Robert P. Sheridan Merck Research Laboratories, USA Satoshi Shuto Hokkaido University, Japan
Romano Silvestri Sapienza University of Rome, Italy Martin Stahl F. Hoffman-La Roche Ltd., Switzerland Takayoshi Suzuki Kyoto Prefectural University of Medicine, Japan Guozhi Tang Ascentage Pharma, China Jonathan L. Vennerstrom University of Nebraska Medical Center, USA Ram A. Vishwakarma Indian Institute of Integrative Medicine, India W. Patrick Walters Vertex Pharmaceuticals, USA Ruth R. Wexler Bristol-Myers Squibb, USA Patrick M. Woster Medical University of South Carolina, USA Qidong You China Pharmaceutical University, China Wendy Young Genetech, USA Ao Zhang Shanghai Institute of Materia Medica, China Weiliang Zhu Shanghai Institute of Materia Medica, China Ex officio Esin Aki-Yalcin Ankara University, Turkey Asian Federation of Medicinal Chemistry Ex officio Yves P. Auberson Novartis Institutes for BioMedical Research, Switzerland European Federation of Medicinal Chemistry Ex officio Paul L. Ornstein Medical College of Wisconsin, USA ACS Division of Medicinal Chemistry Ex officio John E. Macor Bristol-Myers Squibb, USA ACS Division of Medicinal Chemistry
